Compounds > cci 103f

Page last updated: 2024-09-03

cci 103f and Neoplasms

cci 103f has been researched along with Neoplasms in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (11.11)	18.7374
1990's	6 (66.67)	18.2507
2000's	2 (22.22)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Begg, AC; Bussink, J; Kaanders, JH; Ljungkvist, AS; Raleigh, JA; Rijken, PF; van der Kogel, AJ	1
Chou, SC; Ji, X; Kleiter, MM; Lee, DY; Malarkey, DE; Raleigh, JA; Thrall, DE	1
Cline, JM; Raleigh, JA; Rosner, GL; Thrall, DE	2
Cline, JM; La Dine, JK; Raleigh, JA; Thrall, DE	1
Azuma, C; McEntee, MC; Raleigh, JA; Rosner, GL; Thrall, DE	1
Cline, JM; LaDine, JK; Raleigh, JA; Rathman, M; Thrall, DE; Zeman, EM	1
Cline, JM; Franko, AJ; Page, RL; Raleigh, JA; Thrall, DE	1
Best, MW; Franko, AJ; Koch, CJ; Miller, GG; Raleigh, JA	1

Other Studies

9 other study(ies) available for cci 103f and Neoplasms

Article	Year
Hypoxic cell turnover in different solid tumor lines. International journal of radiation oncology, biology, physics, 2005, Jul-15, Volume: 62, Issue:4 Topics: Animals; Benzimidazoles; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Coloring Agents; Half-Life; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Nitroimidazoles; Time Factors	2005
A comparison of oral and intravenous pimonidazole in canine tumors using intravenous CCI-103F as a control hypoxia marker. International journal of radiation oncology, biology, physics, 2006, Feb-01, Volume: 64, Issue:2 Topics: Administration, Oral; Animals; Area Under Curve; Cell Hypoxia; Cell Line; Cricetinae; Cricetulus; Dog Diseases; Dogs; Feasibility Studies; Hydrogen-Ion Concentration; Injections, Intravenous; Neoplasms; Nitroimidazoles	2006
Distribution of the hypoxia marker CCI-103F in canine tumors. International journal of radiation oncology, biology, physics, 1994, Mar-01, Volume: 28, Issue:4 Topics: Animals; Cell Hypoxia; Dog Diseases; Dogs; Female; Male; Neoplasms; Nitroimidazoles	1994
An enzyme-linked immunosorbent assay for hypoxia marker binding in tumours. British journal of cancer, 1994, Volume: 69, Issue:1 Topics: Animals; Biomarkers, Tumor; Calibration; Dogs; Enzyme-Linked Immunosorbent Assay; Hypoxia; Neoplasms; Nitroimidazoles; Tissue Distribution; Tritium	1994
Quantification of CCI-103F labeling heterogeneity in canine solid tumors. International journal of radiation oncology, biology, physics, 1997, Feb-01, Volume: 37, Issue:3 Topics: Analysis of Variance; Animals; Biomarkers; Cell Hypoxia; Dog Diseases; Dogs; Neoplasms; Nitroimidazoles; Oxygen; Reproducibility of Results	1997
Hypoxia marker labeling in tumor biopsies: quantification of labeling variation and criteria for biopsy sectioning. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1997, Volume: 44, Issue:2 Topics: Animals; Biopsy; Cell Hypoxia; Dog Diseases; Dogs; Neoplasms; Nitroimidazoles	1997
Development of an ELISA for the detection of 2-nitroimidazole hypoxia markers bound to tumor tissue. International journal of radiation oncology, biology, physics, 1992, Volume: 22, Issue:3 Topics: Animals; Cell Hypoxia; Dogs; Enzyme-Linked Immunosorbent Assay; Liposarcoma; Neoplasms; Nitroimidazoles; Sarcoma, Synovial	1992
Immunohistochemical detection of a hypoxia marker in spontaneous canine tumours. British journal of cancer, 1990, Volume: 62, Issue:6 Topics: Animals; Cell Hypoxia; Dog Diseases; Dogs; Immunohistochemistry; Neoplasms; Nitroimidazoles; Staining and Labeling	1990
Quantitation of hypoxia in multicellular spheroids by video image analysis. International journal of radiation oncology, biology, physics, 1989, Volume: 16, Issue:4 Topics: Autoradiography; Cell Aggregation; Cell Line; Fluorescence; Humans; Image Processing, Computer-Assisted; Immunoenzyme Techniques; Neoplasms; Nitroimidazoles; Oxygen	1989